Green tea polyphenols

Encyclopedia of Dietary Supplements

Volumn , Issue , 2004, Pages 327-336

  Sang, Shengmin ^a   Lambert, Joshua D ^a   Ho, Chi Tang ^b   Yang, Chung S ^a  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 83555178827     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1081/E-EDS-120022069     Document Type: Chapter

References (67)

1. Yang, C.S.; Maliakal, P.; Meng, X. Inhibition of carcinogenesis by tea. Annu. Rev. Pharmacol. Toxicol. 2002, 42, 25–54.
2. Balentine, D.A.; Paetau-Robinson, I. Tea as a source of dietary antioxidants with a potential role in prevention of chronic diseases. In Herbs, Botanicals, and Teas; Mazza, G., Oomah, B.D., Eds.; Lancaster Technomic Publishing Co. Inc., 2000; 265–287.
3. Balentine, D.A.; Wiseman, S.A.; Bouwens, L.C. The chemistry of tea flavonoids. Crit. Rev. Food Sci. Nutr. 1997, 37 (8), 693–704.
4. Ahmad, N.; Katiyar, S.K.; Mukhtar, H. Anti-oxidants in chemoprevention of skin cancer. Curr. Probl. Dermatol. 2001, 29, 128–139.
5. Cherubini, A.; Beal, M.F.; Frei, B. Black tea increases the resistance of human plasma to lipid peroxidation in vitro, but not ex vivo. Free Radical Biol. Med. 1999, 27 (3-4), 381–387.
6. Vinson, J.A. Black and green tea and heart disease: a review. Biofactors 2000, 13 (1–4), 127–132.
7. Priyadarshi, S.; Valentine, B.; Han, C.; Fedorova, O.V.; Bagrov, A.Y.; Liu, J.; Periyasamy, S.M.; Kennedy, D.; Malhotra, D.; Xie, Z.; Shapiro, J.I. Effect of green tea extract on cardiac hypertrophy following 5=6 nephrectomy in the rat. Kidney Int. 2003, 63 (5), 1785–1790.
8. Hara, Y. The effects of tea polyphenols on cardiovascular diseases. Prev. Med. 1992, 21 (3), 333.
9. Sano, M.; Takahashi, Y.; Yoshino, K.; Shimoi, K.; Nakamura, Y.; Tomita, I.; Oguni, I.; Konomoto, H. Effect of tea (Camellia sinensis L.) on lipid peroxidation in rat liver and kidney: a comparison of green and black tea feeding. Biol. Pharm. Bull. 1995, 18 (7), 1006–1008.
10. Miura, Y.; Chiba, T.; Tomita, I.; Koizumi, H.; Miura, S.; Umegaki, K.; Hara, Y.; Ikeda, M.; Tomita, T. Tea catechins prevent the development of atherosclerosis in apoprotein E-deficient mice. J. Nutr. 2001, 131 (1), 27–32.
11. Tijburg, L.B.; Wiseman, S.A.; Meijer, G.W.; Weststrate, J.A. Effects of green tea, black tea and dietary lipophilic antioxidants on LDL oxidizability and atherosclerosis in hypercholes-terolaemic rabbits. Atherosclerosis 1997, 135 (1), 37–47.
12. Hakim, I.A.; Harris, R.B.; Brown, S.; Chow, H.H.; Wiseman, S.; Agarwal, S.; Talbot, W. Effect of increased tea consumption on oxidative DNA damage among smokers: a randomized controlled study. J. Nutr. 2003, 133 (10), 3303S-3309S.
13. Hirano, R.; Momiyama, Y.; Takahashi, R.; Taniguchi, H.; Kondo, K.; Nakamura, H.; Ohsuzu, F. Comparison of green tea intake in Japanese patients with and without angiographic coronary artery disease. Am. J. Cardiol 2002, 90 (10), 1150-1153.
14. Sasazuki, S.; Kodama, H.; Yoshimasu, K.; Liu, Y.; Washio, M.; Tanaka, K.; Tokunaga, S.; Kono, S.; Arai, H.; Doi, Y.; Kawano, T.; Nakagaki, O.; Takada, K.; Koyanagi, S.; Hiyamuta, K.; Nii, T.; Shirai, K.; Ideishi, M.; Arakawa, K.; Mohri, M.; Takeshita, A. Relation between green tea consumption and the severity of coronary atherosclerosis among Japanese men and women. Ann. Epidemiol. 2000, 10 (6), 401-408.
15. Tan, E.K.; Tan, C; Fook-Chong, S.M.; Lum, S.Y.; Chai, A.; Chung, H.; Shen, H.; Zhao, Y.; Teoh, M.L.; Yih, Y.; Pavanni, R.; Chandran, V.R.; Wong, M.C. Dose-dependent protective effect of coffee, tea, and smoking in Parkinson’s disease: a study in ethnic Chinese. J. Neurol. Sci. 2003, 216 (1), 163-167.
16. Choi, J.Y.; Park, C.S.; Kim, D.J.; Cho, M.H.; Jin, B.K.; Pie, J.E.; Chung, W.G. Prevention of nitric oxide-mediated 1-methyl-4-phenyl-1,2,3,6-tetra-hydropyridine-induced Parkinson’s disease in mice by tea phenolic epigallocatechin 3-gallate. Neurotoxicology 2002, 23 (3), 367-374.
17. Lu, H.; Meng, X.; Yang, C.S. Enzymology of methylation of tea catechins and inhibition of catechol-O-methyltransferase by (—)-epigallocatechin gallate. Drug Metab. Dispos. 2003, 31 (5), 572-579.
18. Jin, C.F.; Shen, S.R., Sr.; Zhao, B.L. Different effects of five catechins on 6-hydroxydopamine-induced apoptosis in PC12 cells. J. Agric. Food Chem. 2001, 49 (12), 6033-6038.
19. Hosoda, K.; Wang, M.F.; Liao, M.L.; Chuang, C.K.; Iha, M.; Clevidence, B.; Yamamoto, S. Antihyperglycemic effect of oolong tea in type 2 diabetes. Diabetes Care 2003, 26 (6), 1714–1718.
20. Dulloo, A.G.; Duret, C; Rohrer, D.; Girardier, L.; Mensi, N.; Fathi, M.; Chantre, P.; Vandermander, J. Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans. Am. J. Clin. Nutr. 1999, 70 (6), 1040-1045.
21. Sabu, M.C; Smitha, K.; Kuttan, R. Anti-diabetic activity of green tea polyphenols and their role in reducing oxidative stress in experimental diabetes. J. Ethnopharmacol. 2002, 83 (1-2), 109-116.
22. Han, M.K. Epigallocatechin gallate, a constituent of green tea, suppresses cytokine-induced pancreatic beta-cell damage. Exp. Mol. Med. 2003, 35 (2), 136-139.
23. Katiyar, S.K.; Elmets, C.A. Green tea poly-phenolic antioxidants and skin photoprotection (review). Int. J. Oncol. 2001, 18 (6), 1307-1313.
24. Weisburger, J.H. Tea and health: the underlying mechanisms. Proc. Soc. Exp. Biol. Med. 1999, 220 (4), 271-275.
25. Chung, F.L.; Schwartz, J.; Herzog, C.R.; Yang, Y.M. Tea and cancer prevention: studies in animals and humans. J. Nutr. 2003, 133 (10), 3268s-3274s.
26. Huang, M.T.; Xie, J.G.; Wang, Z.Y.; Ho, C.T.; Lou, Y.R.; Wang, C.X.; Hard, G.C.; Conney, A.H. Effects of tea, decaffeinated tea, and caffeine on UVB light-induced complete carcinogenesis in SKH-1 mice: demonstration of caffeine as a biologically important constituent of tea. Cancer Res. 1997, 57 (13), 2623-2629.
27. Lu, Y.P.; Lou, Y.R.; Xie, J.G.; Peng, Q.Y.; Liao, J.; Yang, C.S.; Huang, M.T.; Conney, A.H. Topical applications of caffeine or (—)-epigallocatechin gallate (EGCG) inhibit carcinogenesis and selectively increase apoptosis in UVB-induced skin tumors in mice. Proc. Natl. Acad. Sci. U.S.A. 2002, 99 (19), 12455-12460.
28. Zeegers, M.P.; Tan, F.E.; Goldbohm, R.A.; van den Brandt, P.A. Are coffee and tea consumption associated with urinary tract cancer risk? A systematic review and meta-analysis. Int. J. Epidemiol. 2001, 30 (2), 353-362.
29. Blot, W.J.; Chow, W.H.; McLaughlin, J.K. Tea and cancer: a review of the epidemiological evidence. Eur. J. Cancer Prev. 1996, 5 (6), 425-438.
30. Sun, C.L.; Yuan, J.M.; Lee, M.J.; Yang, C.S.; Gao, Y.T.; Ross, R.K.; Yu, M.C. Urinary tea polyphenols in relation to gastric and esophageal cancers: a prospective study of men in Shanghai, China. Carcinogenesis 2002, 23 (9), 1497-1503.
31. Koizumi, Y.; Tsubono, Y.; Nakaya, N.; Nishino, Y.; Shibuya, D.; Matsuoka, H.; Tsuji, I. No association between green tea and the risk of gastric cancer: pooled analysis of two prospective studies in Japan. Cancer Epidemiol. Biomarkers Prev. 2003, 12 (4), 472-473.
32. Su, L.J.; Arab, L. Tea consumption and the reduced risk of colon cancer—results from a national prospective cohort study. Public Health Nutr. 2002, 5 (3), 419–425.
33. Goldbohm, R.A.; Hertog, M.G.; Brants, H.A.; van Poppel, G.; van den Brandt, P.A. Consumption of black tea and cancer risk: a prospective cohort study. J. Natl. Cancer Inst. 1996, 88 (2), 93-100.
34. Chung, L.; Cheung, T.; Kong, S.; Fung, K.; Choy, Y.; Chan, Z.; Kwok, T. Induction of apoptosis by green tea catechins in human prostate cancer DU145 cells. Life Sci. 2001, 68 (10), 1207-1214.
35. Lea, M.; Xiao, Q.; Sadhukhan, A.; Cottle, S.; Wang, Z.Y.; Yang, C.S. Inhibitory effects of tea extracts and (—)-epigallocatechin gallate on DNA synthesis and proliferation of hepatoma and erythroleukemia cells. Cancer Lett. 1993,68 (2-3), 231-236.
36. Uesato, S.; Kitagawa, Y.; Kamishimoto, M.; Kumagai, A.; Hori, H.; Nagasawa, H. Inhibition of green tea catechins against the growth of cancerous human colon and hepatic epithelial cells. Cancer Lett. 2001, 170 (1), 41-44.
37. Yang, G.Y.; Liao, J.; Kim, K.; Yurkow, E.J.; Yang, C.S. Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols. Carcinogenesis 1998, 19 (4), 611-616.
38. Frei, B.; Higdon, J. Antioxidant activity of tea polyphenols in vivo: evidence from animal studies. J. Nutr. 2003, 133 (10), 3275s-3284s.
39. Rietveld, A.; Wiseman, S. Antioxidant effects of tea: evidence from human clinical trials. J. Nutr. 2003, 133 (10), 3285s-3292s.
40. Yang, G.Y.; Liao, J.; Li, C; Chung, J.; Yurkow, E.J.; Ho, C.T.; Yang, C.S. Effect of black and green tea polyphenols on c-jun phosphorylation and H(2)O(2) production in transformed and non-transformed human bronchial cell lines: possible mechanisms of cell growth inhibition and apoptosis induction. Carcinogenesis 2000, 21 (11), 2035-2039.
41. Hong, J.; Lu, H.; Meng, X.; Ryu, J.H.; Hara, Y.; Yang, C.S. Stability, cellular uptake, biotransformation, and efflux of tea polyphenol (—)-epigallocatechin-3-gallate in HT-29 human colon adenocarcinoma cells. Cancer Res. 2002, 62 (9), 7241-7246.
42. Dong, Z. Effects of food factors on signal transduction pathways. Biofactors 2000, 12 (1), 17-28.
43. Yang, F.; Oz, H.S.; Barve, S.; de Villiers, W.J.; McClain, C.J.; Varilek, G.W. The green tea polyphenol (—)-epigallocatechins-3-gallate blocks nuclear factor-kappa B activation by inhibiting I kappa B kinase activity in the intestinal epithelial cell line IEC-6. Mol. Pharmacol. 2001, 60 (3), 528-533.
44. Chung, J.Y.; Park, J.O.; Phyu, H.; Dong, Z.; Yang, C.S. Mechanisms of inhibition of the Ras-MAP kinase signaling pathway in 30.7b Ras 12 cells by tea polyphenols (—)-epigallocate-chin-3-gallate and theaflavin-3,3'-digallate. FASEB J. 2001, 15 (11), 2022-2024.
45. Liang, Y.C.; Lin-shiau, S.Y.; Chen, C.F.; Lin, J.K. Suppression of extracellular signals and cell proliferation through EGF receptor binding by (—)-epigallocatechin gallate in human A431 epidermoid carcinoma cells. J. Cell Biochem. 1997, 67 (1), 55-65.
46. Lambert, J.D.; Yang, C.S. Mechanisms of cancer prevention by tea constituents. J. Nutr. 2003, 133 (10), 3262s-3267s.
47. Lipinski, C.A.; Lombardo, F.; Dominy, B.W.; Feeney, P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 2001, 46 (1), 3-26.
48. Okushio, K.; Suzuki, M.; Matsumoto, N.; Nanjo, F.; Hara, Y. Identification of (—)-epicatechin metabolites and their metabolic fate in the rat. Drug Metab. Dispos. 1999, 27 (2), 309-316.
49. Okushio, K.; Suzuki, M.; Matsumoto, N.; Nanjo, F.; Hara, Y. Methylation of tea catechins by rat liver homogenates. Biosci. Biotech. Biochem. 1999, 63 (2), 430-432.
50. Kida, K.; Suzuki, M.; Matsumoto, N.; Nanjo, F.; Hara, Y. Identification of biliary metabolites of (—)-epigallocatechin gallate in rats. J. Agric. Food Chem. 2000, 48 (9), 4151–4155.
51. Lee, M.J.; Wang, Z.Y.; Li, H.; Chen, L.; Sun, Y.; Gobbo, S.; Balentine, D.; Yang, C.S. Analysis of plasma and urinary tea polyphenols in human subjects. Cancer Epidemiol. Biomarkers Prev 1995, 4 (4), 393-399.
52. Chow, H.H.; Cai, Y.; Alberts, D.S.; Hakim, I.; Dorr, R.; Shahi, F.; Crowell, J.A.; Yang, C.S.; Hara, Y. Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E. Cancer Epidemiol. Biomarkers Prev 2001,10 (1), 53-58.
53. Lu, H. Mechanistic studies on the Phase II metabolism and absorption of tea catechins. In Toxicology; New Brunswick Rutgers, The State University of New Jersey.
54. Li, C; Lee, M.J.; Sheng, S.; Meng, X.; Prabhu, S.; Winnik, B.; Huang, B.; Chung, J.Y.; Yan, S.; Ho, C.T.; Yang, C.S. Structural identification of two metabolites of catechins and their kinetics in human urine and blood after tea ingestion. Chem. Res. Toxicol. 2000, 13 (3), 177-184.
55. Meselhy, M.R.; Nakamura, N.; Hattori, M. Biotransformation of (—)-epicatechin 3-O-gallate by human intestinal bacteria. Chem. Pharm. Bull. (Tokyo) 1997, 45 (5), 888-893.
56. Chen, L.; Lee, M.J.; Li, H.; Yang, C.S. Absorption, distribution, and elimination of tea pol-phenols in rats. Drug Metab. Dispos. 1997, 25 (9), 1045-1050.
57. Nakagawa, K.; Miyazawa, T. Absorption and distribution of tea catechin, (—)-epigallocate- chin-3-gallate, in the rat. Nutr. Sci. Vitaminol 1997, 43 (6), 679-684.
58. Kohri, T.; Matsumoto, N.; Yamakawa, M.; Suzuki, M.; Nanjo, F.; Hara, Y.; Oku, N. Metabolic fate of (—)-[4-(3)H]epigallocatechin gallate in rats after oral administration. J. Agric. Food Chem. 2001, 49 (8), 4102-4112.
59. Suganuma, M.; Okabe, S.; Oniyama, M.; Tada, Y.; Ito, H.; Fujiki, H. Wide distribution of [3H] (—)-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue. Carcinogenesis 1998, 19 (10), 1771-1776.
60. Kohri, T.; Nanjo, F.; Suzuki, M.; Seto, R.; Matsumoto, N.; Yamakawa, M.; Hojo, H.; Hara, Y.; Desai, D.; Amin, S.; Conaway, C; Chung, F.L. Synthesis of (—)-[4-3H]epigallocatechin gallate and its metabolic fate in rats after intravenous administration. J. Agric. Food Chem. 2001, 49 (2), 1042-1048.
61. Kim, S.; Lee, M.J.; Hong, J.; Li, C; Smith, T.J.; Yang, G.Y.; Seril, D.N.; Yang, C.S. Plasma and tissue levels of tea catechins in rats and mice during chronic consumption of green tea polyphenols. Nutr. Cancer 2000, 37 (1), 41-48.
62. Lee, M.J.; Maliakal, P.; Chen, L.; Meng, X.; Bondoc, F.Y.; Prabhu, S.; Lambert, G.; Mohr, S.; Yang, C.S. Pharmacokinetics of tea catechins after ingestion of green tea and (—)-epigallocatechin-3 -gallate by humans: formation of different metabolites and individual variability. Cancer Epidemiol. Biomarkers Prev. 2002, 11 (10), 1025–1032.
63. Yang, C.S.; Chen, L.; Lee, M.J.; Balentine, D.; Kuo, M.C.; Schantz, S.P., Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers. Cancer Epidemiol. Biomarkers Prev 1998, 7 (4), 351–354.
64. Meng, X.; Sang, S.; Zhu, N.; Lu, H.; Sheng, S.; Lee, M.J.; Ho, C.T.; Yang, C.S. Identification and characterization of methylated and ring-fission metabolites of tea catechins formed in humans, mice, and rats. Chem. Res. Toxicol. 2002, 15 (8), 1042–1050.
65. Lambert, J.D.; Lee, M.J.; Lu, H.; Meng, X.; Ju, J.; Hong, J.; Seril, D.N.; Sturgill, M.G.; Yang, C.S. Epigallocatechin-3-gallate is absorbed but extensively glucuronidated following oral administration to mice. J. Nutr. 2003, 133 (12), 4172–4177.
66. Lee, M.J.; Lambert, J.D.; Prabhu, S.; Meng, X.; Lu, H.; Maliakal, P.; Ho, C.T.; Yang, C.S. Delivery of tea polyphenols to the oral cavity by green tea leaves and black tea extract. Cancer Epidemiol. Biomark. Prev 2004, 13 (1), 132–137.
67. Lee, M.J.; Lambert, J.D.; Prabhu, S.; Meng, X.; Lu, H.; Maliakal, P.; Ho, C.T.; Yang, C.S. Delivery of tea polyphenols to the oral cavity by green tea leaves and black tea extract. Cancer Epi. Biomark Prev 2004, 13 (1), 132–137.